A test for rapid detection and management of diabetes has been introduced by EKF Diagnostics
of Cardiff, Wales. Called Quo-Test, the POC analyzer measures glycated hemoglobin (HbA1c) using a patented boronate fluorescence quenching technology that is not affected by hemoglobin variants, the company says, noting that boronate has an affinity for HbA1c.
delivers results in four minutes from 4 μl of blood. The device has a menu with several languages, a barcode reader, and a storage capacity of up to 7000 results that can be downloaded using a USB port, EKF says.
The analyzer has received a CE mark and is awaiting FDA clearance for an expected U.S. launch in early 2013. It has been approved for use in China and will be sold in the Americas by Stanbio Laboratory, a Texas-based IVD distributor that was acquired by EKF in May 2011.